| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TCF4 HOXC6 HIVEP1 ALX1 ZBTB48 ZFHX4 POU4F1 POU4F2 POU4F3 PAX7 ZNF782 MGA NOTCH4 TP73 PASD1 ZNF2 | 1.29e-07 | 1412 | 49 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TCF4 HOXC6 HIVEP1 ZBTB48 ZFHX4 POU4F1 POU4F2 POU4F3 PAX7 ZNF782 MGA NOTCH4 TP73 PASD1 ZNF2 | 2.12e-07 | 1271 | 49 | 15 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TCF4 HOXC6 HIVEP1 ZBTB48 ZFHX4 POU4F1 POU4F2 POU4F3 PAX7 ZNF782 MGA TP73 PASD1 ZNF2 | 1.06e-06 | 1244 | 49 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TCF4 HOXC6 HIVEP1 ALX1 ZBTB48 ZFHX4 POU4F1 POU4F2 POU4F3 PAX7 ZNF782 MGA TP73 PASD1 ZNF2 | 1.23e-06 | 1459 | 49 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 7.60e-06 | 560 | 49 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 8.28e-06 | 566 | 49 | 9 | GO:0001216 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TCF4 IFRD1 HIVEP1 ALX1 POU4F1 POU4F2 POU4F3 PRKDC PAX7 ZNF782 MED23 MGA NOTCH4 TP73 | 2.05e-06 | 1390 | 48 | 14 | GO:0045944 |
| GeneOntologyCellularComponent | transcription regulator complex | 1.21e-06 | 596 | 50 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | TCF4 HOXC6 ALX1 ZFHX4 POU4F1 POU4F2 POU4F3 PRKDC PAX7 MGA INO80D TP73 | 1.47e-04 | 1480 | 50 | 12 | GO:0000785 |
| Domain | Homeobox_CS | 6.04e-07 | 186 | 50 | 7 | IPR017970 | |
| Domain | Homeodomain-like | 2.57e-06 | 332 | 50 | 8 | IPR009057 | |
| Domain | Homeobox | 2.80e-06 | 234 | 50 | 7 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.96e-06 | 236 | 50 | 7 | PS00027 | |
| Domain | HOX | 3.04e-06 | 237 | 50 | 7 | SM00389 | |
| Domain | HOMEOBOX_2 | 3.22e-06 | 239 | 50 | 7 | PS50071 | |
| Domain | Homeobox_dom | 3.22e-06 | 239 | 50 | 7 | IPR001356 | |
| Domain | - | 9.74e-06 | 283 | 50 | 7 | 1.10.10.60 | |
| Domain | POU | 9.86e-06 | 16 | 50 | 3 | SM00352 | |
| Domain | POU_2 | 9.86e-06 | 16 | 50 | 3 | PS00465 | |
| Domain | POU_dom | 9.86e-06 | 16 | 50 | 3 | IPR000327 | |
| Domain | POU_3 | 9.86e-06 | 16 | 50 | 3 | PS51179 | |
| Domain | Pou | 9.86e-06 | 16 | 50 | 3 | PF00157 | |
| Domain | POU_1 | 9.86e-06 | 16 | 50 | 3 | PS00035 | |
| Domain | POU | 1.20e-05 | 17 | 50 | 3 | IPR013847 | |
| Domain | - | 5.05e-05 | 27 | 50 | 3 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 6.28e-05 | 29 | 50 | 3 | IPR010982 | |
| Domain | OAR | 8.23e-04 | 16 | 50 | 2 | PS50803 | |
| Domain | OAR_dom | 8.23e-04 | 16 | 50 | 2 | IPR003654 | |
| Domain | VWF_A | 2.36e-03 | 99 | 50 | 3 | IPR002035 | |
| Domain | hEGF | 2.54e-03 | 28 | 50 | 2 | PF12661 | |
| Domain | Ank_2 | 2.60e-03 | 215 | 50 | 4 | PF12796 | |
| Domain | Ank | 3.21e-03 | 228 | 50 | 4 | PF00023 | |
| Domain | - | 4.33e-03 | 248 | 50 | 4 | 1.25.40.20 | |
| Domain | ANK | 4.52e-03 | 251 | 50 | 4 | SM00248 | |
| Domain | ANK_REPEAT | 4.65e-03 | 253 | 50 | 4 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 4.71e-03 | 254 | 50 | 4 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.71e-03 | 254 | 50 | 4 | PS50297 | |
| Domain | EGF_1 | 4.78e-03 | 255 | 50 | 4 | PS00022 | |
| Domain | EGF-like_CS | 5.18e-03 | 261 | 50 | 4 | IPR013032 | |
| Domain | Ankyrin_rpt | 5.26e-03 | 262 | 50 | 4 | IPR002110 | |
| Domain | EGF_2 | 5.47e-03 | 265 | 50 | 4 | PS01186 | |
| Domain | SAM_2 | 5.91e-03 | 43 | 50 | 2 | PF07647 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 5.01e-06 | 14 | 35 | 3 | M27638 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 5.01e-06 | 14 | 35 | 3 | MM15341 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 9598366 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 21935940 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 8290353 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 7623109 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 31286854 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 7935408 | ||
| Pubmed | Chromosomal localization and sequences of the murine Brn-3 family of developmental control genes. | 2.80e-09 | 3 | 50 | 3 | 8162704 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TCF4 HOXC6 HIVEP1 ALX1 ZBTB48 ZFHX4 POU4F1 POU4F2 POU4F3 PAX7 MGA TP73 | 4.55e-09 | 908 | 50 | 12 | 19274049 |
| Pubmed | Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. | 1.12e-08 | 4 | 50 | 3 | 9256502 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 33135183 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 20826176 | ||
| Pubmed | Genetic interactions between Brn3 transcription factors in retinal ganglion cell type specification. | 1.12e-08 | 4 | 50 | 3 | 24116103 | |
| Pubmed | Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. | 2.79e-08 | 5 | 50 | 3 | 8637595 | |
| Pubmed | The Wilms' tumor gene Wt1 is required for normal development of the retina. | 5.57e-08 | 6 | 50 | 3 | 11889045 | |
| Pubmed | Gfi1-Cre knock-in mouse line: A tool for inner ear hair cell-specific gene deletion. | 5.57e-08 | 6 | 50 | 3 | 20533399 | |
| Pubmed | Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors. | 5.57e-08 | 6 | 50 | 3 | 9630743 | |
| Pubmed | POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. | 5.57e-08 | 6 | 50 | 3 | 8632990 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 22262898 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 11807038 | ||
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 9735355 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 23805044 | ||
| Pubmed | 4.58e-07 | 11 | 50 | 3 | 8876243 | ||
| Pubmed | Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. | 4.58e-07 | 11 | 50 | 3 | 8955272 | |
| Pubmed | The Ciliary Margin Zone of the Mammalian Retina Generates Retinal Ganglion Cells. | 4.58e-07 | 11 | 50 | 3 | 28009286 | |
| Pubmed | Ascl1 expression defines a subpopulation of lineage-restricted progenitors in the mammalian retina. | 6.09e-07 | 12 | 50 | 3 | 21771810 | |
| Pubmed | Integral bHLH factor regulation of cell cycle exit and RGC differentiation. | 1.26e-06 | 15 | 50 | 3 | 29770538 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27391320 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8537352 | ||
| Pubmed | Brn3 transcription factors control terminal osteoclastogenesis. | 2.03e-06 | 2 | 50 | 2 | 17668438 | |
| Pubmed | Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription. | 2.03e-06 | 2 | 50 | 2 | 18421303 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8995448 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8234287 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17189620 | ||
| Pubmed | POU4F3 Is Necessary for Normal Merkel Cell Formation, whereas POU4F1 Is Dispensable. | 2.03e-06 | 2 | 50 | 2 | 39009281 | |
| Pubmed | A single amino acid change converts an inhibitory transcription factor into an activator. | 2.03e-06 | 2 | 50 | 2 | 8662774 | |
| Pubmed | Autoregulatory sequences are revealed by complex stability screening of the mouse brn-3.0 locus. | 2.03e-06 | 2 | 50 | 2 | 10414983 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 7904822 | ||
| Pubmed | NT-3 regulates expression of Brn3a but not Brn3b in developing mouse trigeminal sensory neurons. | 2.03e-06 | 2 | 50 | 2 | 9582431 | |
| Pubmed | Differential expression and subcellular localization of Copines in mouse retina. | 2.03e-06 | 2 | 50 | 2 | 30866042 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8248179 | ||
| Pubmed | 4.22e-06 | 22 | 50 | 3 | 22326227 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 17145718 | ||
| Pubmed | No association between POU4F1, POU4F2, ISL1 polymorphisms and normal-tension glaucoma. | 6.07e-06 | 3 | 50 | 2 | 32597291 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20673877 | ||
| Pubmed | Doppel expression is regulated by the Brn-3a and Brn-3b transcription factors. | 6.07e-06 | 3 | 50 | 2 | 15094508 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24736625 | ||
| Pubmed | Pou4f2-GFP knock-in mouse line: A model for studying retinal ganglion cell development. | 6.07e-06 | 3 | 50 | 2 | 27532212 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9448000 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 33615686 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 38691453 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24608965 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19323995 | ||
| Pubmed | 6.29e-06 | 25 | 50 | 3 | 22411557 | ||
| Pubmed | 8.93e-06 | 28 | 50 | 3 | 38344749 | ||
| Pubmed | 1.10e-05 | 30 | 50 | 3 | 31399471 | ||
| Pubmed | Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7. | 1.21e-05 | 4 | 50 | 2 | 31852888 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 36384141 | ||
| Pubmed | DeltaNp73 transcription factors modulate cell survival and tumor development. | 1.21e-05 | 4 | 50 | 2 | 20372082 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 28775681 | ||
| Pubmed | Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1. | 1.22e-05 | 31 | 50 | 3 | 16702404 | |
| Pubmed | Reelin signaling facilitates maturation of CA1 glutamatergic synapses. | 2.02e-05 | 5 | 50 | 2 | 17229826 | |
| Pubmed | Gli1 marks a sentinel muscle stem cell population for muscle regeneration. | 2.02e-05 | 5 | 50 | 2 | 37914731 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 18368538 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 10716451 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 35988153 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 19924248 | ||
| Pubmed | Developmental roles of p73 in Cajal-Retzius cells and cortical patterning. | 2.02e-05 | 5 | 50 | 2 | 15525772 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 21828091 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 9004271 | ||
| Pubmed | Cajal-Retzius neurons are required for the development of the human hippocampal fissure. | 2.02e-05 | 5 | 50 | 2 | 30861578 | |
| Pubmed | The emergence of transcriptional identity in somatosensory neurons. | 2.02e-05 | 5 | 50 | 2 | 31915380 | |
| Pubmed | Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. | 2.02e-05 | 5 | 50 | 2 | 10227978 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 2.57e-05 | 118 | 50 | 4 | 19156168 | |
| Pubmed | The C terminus of p73 is essential for hippocampal development. | 3.03e-05 | 6 | 50 | 2 | 32571922 | |
| Pubmed | Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. | 3.03e-05 | 6 | 50 | 2 | 19525941 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 35584694 | ||
| Pubmed | Expression of a large family of POU-domain regulatory genes in mammalian brain development. | 3.03e-05 | 6 | 50 | 2 | 2739723 | |
| Pubmed | Direct Reprogramming of Mouse Fibroblasts into Functional Skeletal Muscle Progenitors. | 3.03e-05 | 6 | 50 | 2 | 29742392 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 28594399 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 27259519 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.46e-05 | 430 | 50 | 6 | 35044719 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 21664258 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 36982451 | ||
| Pubmed | mNUDC is required for plus-end-directed transport of cytoplasmic dynein and dynactins by kinesin-1. | 4.23e-05 | 7 | 50 | 2 | 20019668 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 26962139 | ||
| Pubmed | mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). | 4.23e-05 | 7 | 50 | 2 | 24870234 | |
| Pubmed | Class I histone deacetylases in retinal progenitors and differentiating ganglion cells. | 4.23e-05 | 7 | 50 | 2 | 30179675 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 25087979 | ||
| Pubmed | NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice. | 4.23e-05 | 7 | 50 | 2 | 16438943 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 24709358 | ||
| Pubmed | Analysis of Kif5b expression during mouse kidney development. | 4.23e-05 | 7 | 50 | 2 | 25885434 | |
| Pubmed | Spatiotemporal gene expression patterns reveal molecular relatedness between retinal laminae. | 4.92e-05 | 49 | 50 | 3 | 31609468 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 28592560 | ||
| Pubmed | Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia. | 5.64e-05 | 8 | 50 | 2 | 29920276 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 21177349 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 19805388 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 19571808 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 37733805 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 10823961 | ||
| Pubmed | Ascl1 participates in Cajal-Retzius cell development in the neocortex. | 5.64e-05 | 8 | 50 | 2 | 21467208 | |
| Cytoband | 1p36.3 | 1.05e-04 | 14 | 50 | 2 | 1p36.3 | |
| Cytoband | 7q22 | 7.97e-04 | 38 | 50 | 2 | 7q22 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 1.36e-05 | 23 | 37 | 3 | 523 | |
| Coexpression | KRAS.300_UP.V1_UP | 7.84e-06 | 143 | 50 | 5 | M2875 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.49e-05 | 591 | 50 | 8 | M2019 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.68e-05 | 601 | 50 | 8 | MM866 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_24H_BMDC_DN | 3.85e-05 | 199 | 50 | 5 | M3821 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 4.86e-05 | 345 | 50 | 6 | M2009 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 5.01e-05 | 347 | 50 | 6 | MM860 | |
| Coexpression | HEVNER_CORTEX_CAJAL_RETZIUS_CELLS | 9.91e-05 | 8 | 50 | 2 | MM394 | |
| Coexpression | DESCARTES_FETAL_EYE_GANGLION_CELLS | 1.20e-04 | 50 | 50 | 3 | M40185 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 1.31e-04 | 1035 | 50 | 9 | M9898 | |
| Coexpression | BENPORATH_EED_TARGETS | 1.56e-04 | 1059 | 50 | 9 | M7617 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 1.68e-04 | 272 | 50 | 5 | M1938 | |
| Coexpression | KRAS.600_UP.V1_UP | 1.89e-04 | 279 | 50 | 5 | M2882 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 1.98e-04 | 282 | 50 | 5 | MM822 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 2.21e-04 | 650 | 50 | 7 | M8448 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 2.29e-04 | 1115 | 50 | 9 | M10371 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.07e-08 | 194 | 50 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.32e-08 | 195 | 50 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 1.68e-06 | 178 | 50 | 5 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 184 | 50 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 184 | 50 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 184 | 50 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.25e-06 | 189 | 50 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.50e-06 | 193 | 50 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-06 | 194 | 50 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.63e-06 | 195 | 50 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.69e-06 | 196 | 50 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 197 | 50 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 197 | 50 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.90e-06 | 199 | 50 | 5 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-05 | 122 | 50 | 4 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 147 | 50 | 4 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 147 | 50 | 4 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 148 | 50 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-05 | 168 | 50 | 4 | 5a2e7a52b7330dce30823695a7b9b26bc47a69ce | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.87e-05 | 169 | 50 | 4 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.96e-05 | 170 | 50 | 4 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.05e-05 | 171 | 50 | 4 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.05e-05 | 171 | 50 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 4.14e-05 | 172 | 50 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.14e-05 | 172 | 50 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 4.14e-05 | 172 | 50 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | IIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 4.24e-05 | 173 | 50 | 4 | 4f2843371d18af766c1892529ce286f56c956fde | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 4.43e-05 | 175 | 50 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 4.43e-05 | 175 | 50 | 4 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 4.43e-05 | 175 | 50 | 4 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 176 | 50 | 4 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 4.53e-05 | 176 | 50 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 4.53e-05 | 176 | 50 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 177 | 50 | 4 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 4.73e-05 | 178 | 50 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 4.73e-05 | 178 | 50 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 178 | 50 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-05 | 179 | 50 | 4 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-05 | 179 | 50 | 4 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 181 | 50 | 4 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 5.05e-05 | 181 | 50 | 4 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 5.05e-05 | 181 | 50 | 4 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 5.16e-05 | 182 | 50 | 4 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.16e-05 | 182 | 50 | 4 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.38e-05 | 184 | 50 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-05 | 184 | 50 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 185 | 50 | 4 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 5.50e-05 | 185 | 50 | 4 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.50e-05 | 185 | 50 | 4 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.61e-05 | 186 | 50 | 4 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 186 | 50 | 4 | 7a8da2ad140bea3207bd868212cc5e201d586772 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 186 | 50 | 4 | dc394034929c6b10ae0e1c1a028cc3d4ce873298 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.73e-05 | 187 | 50 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 5.73e-05 | 187 | 50 | 4 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-05 | 189 | 50 | 4 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-05 | 189 | 50 | 4 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.10e-05 | 190 | 50 | 4 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 50 | 4 | 318323a12029a7992f16382cb0c186f5b2e1ca47 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 50 | 4 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 50 | 4 | 4aa29337f4d2528577bb90dc4abfb6eab93e120f | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 50 | 4 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 192 | 50 | 4 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 6.35e-05 | 192 | 50 | 4 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 192 | 50 | 4 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 192 | 50 | 4 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 193 | 50 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 6.48e-05 | 193 | 50 | 4 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 6.48e-05 | 193 | 50 | 4 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 194 | 50 | 4 | 4e93bd903cddfd0c8f220b6a35b449895de4119b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 50 | 4 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 194 | 50 | 4 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 50 | 4 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 194 | 50 | 4 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 50 | 4 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.61e-05 | 194 | 50 | 4 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-05 | 194 | 50 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 194 | 50 | 4 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 6.61e-05 | 194 | 50 | 4 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 50 | 4 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.74e-05 | 195 | 50 | 4 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 195 | 50 | 4 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.74e-05 | 195 | 50 | 4 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.74e-05 | 195 | 50 | 4 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.88e-05 | 196 | 50 | 4 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.88e-05 | 196 | 50 | 4 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.88e-05 | 196 | 50 | 4 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 6.88e-05 | 196 | 50 | 4 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 6.88e-05 | 196 | 50 | 4 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.01e-05 | 197 | 50 | 4 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.01e-05 | 197 | 50 | 4 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.01e-05 | 197 | 50 | 4 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 198 | 50 | 4 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 4.37e-06 | 196 | 50 | 6 | 4813_DN | |
| Disease | Alveolar rhabdomyosarcoma | 2.80e-05 | 5 | 50 | 2 | C0206655 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 4.20e-05 | 6 | 50 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Paranoia | 1.53e-04 | 11 | 50 | 2 | C1456784 | |
| Disease | post-traumatic stress disorder | 3.84e-04 | 202 | 50 | 4 | EFO_0001358 | |
| Disease | tonsillectomy risk measurement | 9.87e-04 | 260 | 50 | 4 | EFO_0007924 | |
| Disease | susceptibility to rheumatic fever measurement | 1.03e-03 | 28 | 50 | 2 | EFO_0008416 | |
| Disease | stimulant use measurement | 1.03e-03 | 28 | 50 | 2 | EFO_0600076 | |
| Disease | Bipolar Disorder | 1.26e-03 | 477 | 50 | 5 | C0005586 | |
| Disease | atopic eczema, psoriasis | 1.71e-03 | 36 | 50 | 2 | EFO_0000274, EFO_0000676 | |
| Disease | Takayasu arteritis | 2.04e-03 | 148 | 50 | 3 | EFO_1001857 | |
| Disease | worry measurement | 2.28e-03 | 154 | 50 | 3 | EFO_0009589 | |
| Disease | epilepsy (implicated_via_orthology) | 2.68e-03 | 163 | 50 | 3 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSCMTPYSHSPRTDS | 246 | Q15699 | |
| HPNNYPSSSSSMSNC | 146 | Q8IYX3 | |
| TGMSCSDHVTVDSPY | 381 | Q7Z5L2 | |
| HSFSSYSDSFMNPAA | 356 | P23759 | |
| QYTFSMPSDSHVSSC | 71 | Q07108 | |
| TYHTMNSVPCTSTST | 81 | Q01851 | |
| SSCNEGESSSTSYMH | 1311 | Q8IWI9 | |
| HQESLTDYCSMSSYS | 1831 | Q38SD2 | |
| MLGNSSHIPQSSSYC | 241 | P15884 | |
| TTPEYVFHCQSSVMS | 331 | O14576 | |
| CHQSYSEMSCSYTLA | 1196 | Q9ULK4 | |
| FPMADGHTDSYSTSA | 536 | Q13136 | |
| FASCCAHTFSSMSPR | 96 | Q6TCH4 | |
| MPSCQEFTSASIYHA | 971 | P78509 | |
| VHMFVDSDSTYCSST | 256 | Q8IV76 | |
| MNSYFTNPSLSCHLA | 1 | P09630 | |
| HSPYAQPSSTFDTMS | 96 | O15350 | |
| LAMHYSPDASTAFSS | 51 | P00156 | |
| YSFAPISMHCNKSSA | 556 | P09172 | |
| YVYSTNSDHLPMTSS | 171 | Q9P2S6 | |
| CSTFSTAFPGTMYQH | 161 | Q9NSI6 | |
| ASIETMSHCSGYSDP | 46 | O00458 | |
| MSHCSGYSDPSSFAE | 51 | O00458 | |
| PHTTSYSGDNMAATF | 846 | Q53TQ3 | |
| ATPSSTSDMYFANSC | 961 | Q12840 | |
| FPSTCGHYAMSTVSN | 176 | O95487 | |
| ISVASYSPMSSQDHS | 801 | Q9P2F6 | |
| SYSHQSMQSTCSPES | 1061 | Q8IWB6 | |
| ESASYSSVCSHMAET | 1116 | O95255 | |
| TMHFSTCEEFLSSYI | 306 | Q8NE09 | |
| TYHTMNTIPCTSAAS | 141 | Q12837 | |
| SSSFPAYMSKTQCYH | 51 | Q5SWH9 | |
| AYMSKTQCYHTSPCS | 56 | Q5SWH9 | |
| VTTSMSCTDFSFHFP | 701 | P20701 | |
| PDATYHTMSSVPCTS | 76 | Q15319 | |
| ESPATHSSNFLYGTM | 2666 | Q4LDE5 | |
| YTGPTCSEEMTACHS | 721 | Q99466 | |
| SHTGEMPYKCSSCSQ | 371 | P10074 | |
| SFEMTTGHTYPRSCC | 166 | Q9UKR8 | |
| SSNNTYPHLSCFSMK | 3461 | Q86UP3 | |
| MSHTGESPYECSVCS | 221 | Q9BSG1 | |
| ESIYQAMTHFSCLSS | 1416 | Q8NB66 | |
| SMHSPCANDLFYSMT | 151 | Q9HCQ7 | |
| CSHPVICSLSTMYTF | 6 | Q9BS91 | |
| NGHSFCSSSVMTYSK | 101 | P58340 | |
| THSSTFCMRTFGYNT | 46 | P55017 | |
| FVSHPSTTCREQMYN | 2461 | P78527 | |
| DCEYSQISTHSSSPM | 11 | Q8IZN3 | |
| HPCTETFSYQSTFSV | 341 | Q6ZMW2 | |
| QSSCTSYTVHMSAAQ | 256 | P15822 | |
| SSCLSSMEYYDPHTN | 611 | Q9NR64 | |
| TAYHSSPGSTQTMHF | 4746 | Q9UKN1 | |
| STHCRSCLSNMPTYS | 1211 | Q12879 |